{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:45:54Z","timestamp":1760298354304},"reference-count":43,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1253\/circj.cj-10-0670","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T05:20:31Z","timestamp":1303104031000},"page":"1463-1471","source":"Crossref","is-referenced-by-count":21,"title":["Activation of Endothelin-1 Receptor Signaling Pathways Is Associated With Neointima Formation, Neoangiogenesis and Irreversible Pulmonary Artery Hypertension in Patients With Congenital Heart Disease"],"prefix":"10.1253","volume":"75","author":[{"given":"HaiQiong","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Zhongshan Hospital affiliated with Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Qilu Hospital affiliated with Shandong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathology, Cleveland Clinic Pathology & Laboratory Medicine Institute and the Lerner College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Huashan Hospital affiliated with Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Zhongshan Hospital affiliated with Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007; 115: 1039-1050.","DOI":"10.1161\/CIRCULATIONAHA.105.592386"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Toyoda T, Tateno S, Kawasoe Y, Shirai T, Shiina Y, Matsuo K, et al. Nationwide survey of care facilities for adults with congenital heart disease in Japan. Circ J 2009; 73: 1147-1150.","DOI":"10.1253\/circj.CJ-08-0922"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lee JW, Song JM, Park JP, Lee JW, Kang DH, Song JK. Long-term prognosis of isolated significant tricuspid regurgitation. Circ J 2010; 74: 375-380.","DOI":"10.1253\/circj.CJ-09-0679"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1253\/circj.70.1655"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Beghetti M, Tissot C. Pulmonary arterial hypertension in congenital heart diseases. Semin Respir Crit Care Med 2009; 30: 421-428.","DOI":"10.1055\/s-0029-1233311"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Beghetti M, Black SM, Fineman JR. Endothelin-1 in congenital heart disease. Pediatr Res 2005; 57: 16R-20R.","DOI":"10.1203\/01.PDR.0000160447.83332.13"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.2174\/157016107779317161"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wort SJ, Woods M, Warner TD, Evans TW, Mitchell JA. Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: Relevance to pathogenesis of pulmonary hypertension and vascular remodeling. Am J Respir Cell Mol Biol 2001; 25: 104-110.","DOI":"10.1165\/ajrcmb.25.1.4331"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP, et al. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 2001; 120: 1562-1569.","DOI":"10.1378\/chest.120.5.1562"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403601200"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chen D, Balyakina EV, Lawrence M, Christman BW, Meyrick B. Cyclooxygenase is regulated by ET-1 and MAPKs in peripheral lung microvascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2003; 284: L614-L621.","DOI":"10.1152\/ajplung.00215.2002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Davie N, Haleen SJ, Upton PD, Polak JM, Yacoub MH, Morrell NW, et al. ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 2002; 165: 398-405.","DOI":"10.1164\/ajrccm.165.3.2104059"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rice KM, Uddemarri S, Desai DH, Morrison RG, Harris R, Wright GL, et al. PGF2alpha-associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN. Prostaglandins Other Lipid Mediat 2008; 85: 49-57.","DOI":"10.1016\/j.prostaglandins.2007.10.009"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009; 179: 615-621.","DOI":"10.1164\/rccm.200811-1691OC"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Dimopoulos K, Peset A, Gatzoulis MA. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. Int J Cardiol 2008; 129: 163-171.","DOI":"10.1016\/j.ijcard.2008.02.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958; 18: 533-547.","DOI":"10.1161\/01.CIR.18.4.533"},{"issue":"4","key":"17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1165\/ajrcmb.20.4.3356","volume":"20","author":"SOMA S","year":"1999","ISSN":"http:\/\/id.crossref.org\/issn\/1044-1549","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Rame JE. Pulmonary hypertension complicating congenital heart disease. Curr Cardiol Rep 2009; 11: 314-320.","DOI":"10.1007\/s11886-009-0045-5"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21446"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Eicken A, Balling G, Gildein HP, Genz T, Kaemmerer H, Hess J. Transcatheter closure of a non-restrictive patent ductus arteriosus with an Amplatzer muscular ventricular septal defect occluder. Int J Cardiol 2007; 117: e40-e42.","DOI":"10.1016\/j.ijcard.2006.10.023"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2005.05.062"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, et al; American College of Chest Physicians. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126: 14S-34S.","DOI":"10.1378\/chest.126.1_suppl.14S"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hoeper MM, Oudiz RJ, Peacock A, Tapson VF, Haworth SG, Frost AE, et al. End points and clinical trial designs in pulmonary arterial hypertension: Clinical and regulatory perspectives. J Am Coll Cardiol 2004; 43: 48S-55S.","DOI":"10.1016\/j.jacc.2004.02.010"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Balzer DT, Kort HW, Day RW, Corneli HM, Kovalchin JP, Cannon BC, et al. Inhaled Nitric Oxide as a Preoperative Test (INOP Test I): The INOP Test Study Group. Circulation 2002; 106: I76-I81.","DOI":"10.1161\/01.cir.0000032875.55215.cb"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kawut SM, Horn EM, Berekashvili KK, Garofano RP, Goldsmith RL, Widlitz AC, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 2005; 95: 199-203.","DOI":"10.1016\/j.amjcard.2004.09.006"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Fried R, Falkovsky G, Newburger J, Gorchakova AI, Rabinovitch M, Gordonova MI, et al. Pulmonary arterial changes in patients with ventricular septal defects and severe pulmonary hypertension. Pediatr Cardiol 1986; 7: 147-154.","DOI":"10.1007\/BF02424988"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Rabinovitch M, Keane JF, Norwood WI, Castaneda AR, Reid L. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation 1984; 69: 655-667.","DOI":"10.1161\/01.CIR.69.4.655"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1078\/0344-0338-00457"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Chin KM, Rubin LJ. Pulmonary arterial hypertension. J Am Coll Cardiol 2008; 51: 1527-1538.","DOI":"10.1016\/j.jacc.2008.01.024"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Shi-Wen X, Chen Y, Denton CP, Eastwood M, Renzoni EA, Bou-Gharios G, et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac\/phosphoinositide 3-kinase\/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 2004; 15: 2707-2719.","DOI":"10.1091\/mbc.e03-12-0902"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.17203160"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000102381.57477.50"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1002\/path.953"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Lévy M, Maurey C, Celermajer DS, Vouhé PR, Danel C, Bonnet D, et al. Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease. J Am Coll Cardiol 2007; 49: 803-810.","DOI":"10.1016\/j.jacc.2006.09.049"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.03419"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.1999.069"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Salani D, Taraboletti G, Rosanò L, Di Castro V, Borsotti P, Giavazzi R, et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 2000; 157: 1703-1711.","DOI":"10.1016\/S0002-9440(10)64807-9"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Knowles J, Loizidou M, Taylor I. Endothelin-1 and angiogenesis in cancer. Curr Vasc Pharmacol 2005; 3: 309-314.","DOI":"10.2174\/157016105774329462"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000022200.71892.9F"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Richardson CJ, Schalm SS, Blenis J. PI3-kinase and TOR: PIKTORing cell growth. Semin Cell Dev Biol 2004; 15: 147-159.","DOI":"10.1016\/j.semcdb.2003.12.023"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.1.200-216.2004"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00117-3"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Easton JB, Houghton PJ. Therapeutic potential of target of rapamycin inhibitors. Expert Opin Ther Targets 2004; 8: 551-564.","DOI":"10.1517\/14728222.8.6.551"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/75\/6\/75_CJ-10-0670\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T10:31:34Z","timestamp":1686047494000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/75\/6\/75_CJ-10-0670\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-10-0670","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}